20.89
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACAD Giù?
Forum
Previsione
Acadia Pharmaceuticals Inc Borsa (ACAD) Ultime notizie
Ranking ACADIA Pharmaceuticals Inc. among high performing stocks via toolsIndex Update & Free Growth Oriented Trading Recommendations - newser.com
Why ACADIA Pharmaceuticals Inc. stock could be next big winnerQuarterly Portfolio Summary & Free Weekly Chart Analysis and Trade Guides - Trung tâm Dự báo KTTV quốc gia
The Past Five Years for ACADIA Pharmaceuticals (NASDAQ:ACAD) Investors Has Not Been Profitable - 富途牛牛
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
Acadia Pharmaceuticals to Announce Third Quarter 2025 Financial Results on November 5, 2025 - Business Wire
Real time alert setup for ACADIA Pharmaceuticals Inc. performanceBear Alert & Detailed Earnings Play Strategies - newser.com
Using Bollinger Bands to evaluate ACADIA Pharmaceuticals Inc.July 2025 Technicals & Daily Entry Point Alerts - newser.com
How sentiment analysis helps forecast ACADIA Pharmaceuticals Inc.Rate Hike & Fast Gaining Stock Reports - newser.com
Is ACADIA Pharmaceuticals Inc. stock trading near support levelsWeekly Gains Summary & Risk Managed Trade Strategies - newser.com
ACADIA Pharmaceuticals Shows Rising Relative Price Performance; Still Shy Of Key Benchmark - Investor's Business Daily
Using flow based indicators on ACADIA Pharmaceuticals Inc.2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com
Should You Be Adding ACADIA Pharmaceuticals (NASDAQ:ACAD) To Your Watchlist Today? - Yahoo Finance
How to track smart money flows in ACADIA Pharmaceuticals Inc.2025 Trading Volume Trends & Entry Point Confirmation Signals - newser.com
How to interpret RSI for ACADIA Pharmaceuticals Inc. stockWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc.ACAD - cnhinews.com
Applying Elliott Wave Theory to ACADIA Pharmaceuticals Inc.Weekly Loss Report & Risk Adjusted Swing Trade Ideas - newser.com
Leerink Partnrs Issues Optimistic Outlook for ACAD Earnings - MarketBeat
Heatmap analysis for ACADIA Pharmaceuticals Inc. and competitors2025 Pullback Review & Weekly Market Pulse Alerts - newser.com
How high can ACADIA Pharmaceuticals Inc. stock go2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
Detecting support and resistance levels for ACADIA Pharmaceuticals Inc.2025 Macro Impact & Verified Momentum Watchlists - newser.com
Q3 EPS Estimate for ACADIA Pharmaceuticals Cut by Analyst - MarketBeat
RBC Cuts Price Target on ACADIA Pharmaceuticals to $34 From $40, Keeps Outperform Rating - MarketScreener
Acadia Healthcare Company, Inc. Announces Chief Financial Officer Changes, Effective October 27, 2025 - MarketScreener
What drives ACADIA Pharmaceuticals Inc stock priceHead and Shoulders Patterns & Double Digit Capital Growth - earlytimes.in
Real time social sentiment graph for ACADIA Pharmaceuticals Inc.Volume Spike & Weekly Chart Analysis and Trade Guides - newser.com
Detecting price anomalies in ACADIA Pharmaceuticals Inc. with AI2025 Price Action Summary & Weekly Chart Analysis and Trade Guides - newser.com
ACADIA Pharmaceuticals: Nuplazid And Daybue Are Enough To Remain Bullish (ACAD) - Seeking Alpha
Is ACADIA Pharmaceuticals Inc. stock attractive after correctionRate Hike & Weekly High Conviction Ideas - newser.com
Wealth Enhancement Advisory Services LLC Makes New $511,000 Investment in ACADIA Pharmaceuticals Inc. $ACAD - Defense World
Intraday pattern recognizer results for ACADIA Pharmaceuticals Inc.2025 Trading Recap & Technical Entry and Exit Alerts - newser.com
Using R and stats models for ACADIA Pharmaceuticals Inc. forecastingWall Street Watch & Reliable Intraday Trade Alerts - newser.com
News impact scoring models applied to ACADIA Pharmaceuticals Inc.2025 Sector Review & Stock Portfolio Risk Control - newser.com
What machine learning models say about ACADIA Pharmaceuticals Inc.Swing Trade & Expert Verified Stock Movement Alerts - newser.com
Will ACADIA Pharmaceuticals Inc. rebound enough to break even2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Acadia Pharmaceuticals’ Investigational Drug For Rare Genetic Disorder Fails In Late-Stage Study - MSN
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
ACADIA Pharmaceuticals Inc. Securities Lawsuit Investigation - Claim Depot
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):